NCT06845553View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions

Knee Osteoarthritis (Knee OA)

Interventions

DRUG

Vutiglabridin

Once-daily oral administration

DRUG

Placebo

Once-daily oral administration

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Seoul National University Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

lead

Glaceum

INDUSTRY

NCT06845553 - A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients | Biotech Hunter | Biotech Hunter